Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy
This study has been completed.
Sponsor:
Charite University, Berlin, Germany
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01530802
First received: November 1, 2010
Last updated: February 9, 2012
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim is to verify, whether intraoperative temporary clipping of the uterine vessels with vascular clips can reduce blood loss significantly.
| Condition | Intervention |
|---|---|
|
Leiomyoma Laparoscopic Myomectomy |
Procedure: clipping of uterine arteries during laparoscopic myomectomy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) |
| Official Title: | Reduction of Intraoperative Blood Loss During Laparoscopic Myomectomy by Temporary Clipping of the Uterine Arteries |
Resource links provided by NLM:
Further study details as provided by Charite University, Berlin, Germany:
Primary Outcome Measures:
- Blood loss during laparoscopic myomectomy [ Time Frame: perioperative (preop and postoperative day3) ] [ Designated as safety issue: No ]hemoglobin drop transfusion rate
Secondary Outcome Measures:
- Patency of uterine artery after laparoscopic clipping [ Time Frame: perioperative ] [ Designated as safety issue: Yes ]Doppler results of the uterine arteries
| Enrollment: | 166 |
| Study Start Date: | January 2007 |
| Estimated Study Completion Date: | December 2009 |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Uterine artery clipped
Both uterine arteries are temporarily clipped by Yasargil clips during laparoscopic myomectomy.
|
Procedure: clipping of uterine arteries during laparoscopic myomectomy
For laparoscopy standard instruments were used.For vascular clamping we used titan made YASARGIL vessel clips. The patient is put in a 20° Trendelenburg. The surgeon coagulates a 3-4 cm long segment of peritoneum over the ileopsoas muscle. Along the coagulated segment the peritoneum is opened. The surgeon identifies the ureter at its crossing over the common iliac vessels. After medializing the ureter, the pararectal space is opened and the internal iliac artery is identified and dissected till the origin of the uterine artery. The uterine artery is isolated over a distance of about 2 cm. The vascular clip is placed over the uterine artery. Yasargil Clips are applied exclusively in patients of intervention group. Myomectomy is performed in identical fashion in both groups. At the end of myomectomy the vessel clips are removed. The metroplasty is controlled for hemostasis after reopening of the uterine vessels.
|
|
No Intervention: Control group
Conventional laparoscopic myomectomy is performed. (No intervention to temporarily occlude uterine arteries is made)
|
Procedure: clipping of uterine arteries during laparoscopic myomectomy
For laparoscopy standard instruments were used.For vascular clamping we used titan made YASARGIL vessel clips. The patient is put in a 20° Trendelenburg. The surgeon coagulates a 3-4 cm long segment of peritoneum over the ileopsoas muscle. Along the coagulated segment the peritoneum is opened. The surgeon identifies the ureter at its crossing over the common iliac vessels. After medializing the ureter, the pararectal space is opened and the internal iliac artery is identified and dissected till the origin of the uterine artery. The uterine artery is isolated over a distance of about 2 cm. The vascular clip is placed over the uterine artery. Yasargil Clips are applied exclusively in patients of intervention group. Myomectomy is performed in identical fashion in both groups. At the end of myomectomy the vessel clips are removed. The metroplasty is controlled for hemostasis after reopening of the uterine vessels.
|
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients are eligible for the study when between 18 and 50 years of age,
- diagnosed with either symptomatic or asymptomatic leiomyomata, and with desire to keep the uterus, and whose leiomyomata had a minimal combined diameter of ≥ 4 cm.
Exclusion Criteria:
- patients with severe accompanying medical problems, or
- with psychiatric illnesses, which jeopardize the participation, or
- undergoing treatment affecting coagulation and/or hematopoiesis, and
- patients with suspected malignancy.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Giuseppe Vercellino, Department of Gynecology, Charité Universitätsmedizin, Berlin - Germany |
| ClinicalTrials.gov Identifier: | NCT01530802 History of Changes |
| Other Study ID Numbers: | EA4/07906 |
| Study First Received: | November 1, 2010 |
| Last Updated: | February 9, 2012 |
| Health Authority: | Germany: Arztekammer Berlin |
Keywords provided by Charite University, Berlin, Germany:
|
laparoscopic myomectomy, leiomyoma, blood loss, uterine artery |
Additional relevant MeSH terms:
|
Leiomyoma Myofibroma Neoplasms, Muscle Tissue Neoplasms, Connective and Soft Tissue |
Neoplasms by Histologic Type Neoplasms Neoplasms, Connective Tissue Connective Tissue Diseases |
ClinicalTrials.gov processed this record on June 18, 2013